Search

Search Constraints

You searched for: Author/Creator Giraudier, Stéphane

Search Results

2. Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study. Issue 4 (12th January 2018)

3. Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study). (10th October 2022)

5. Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome. (4th July 2019)

7. Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study. Issue 1 (January 2015)

8. Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement. (25th September 2021)

9. Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia. Issue 22 (25th July 2017)